# Evaluation of Novel Diagnostic Tests for COVID-19

> **NCT04326387** · — · UNKNOWN · sponsor: **CCTU- Cancer Theme** · enrollment: 200 (estimated)

## Conditions studied

- Acute Disease
- Coronavirus
- Respiratory Viral Infection

## Interventions

- **DIAGNOSTIC_TEST:** SAMBA II (Diagnostic for the Real World)
- **DIAGNOSTIC_TEST:** Public Health England Gold Standard
- **DIAGNOSTIC_TEST:** Cambridge Validated Viral Detection Method
- **DIAGNOSTIC_TEST:** Radiological Detection

## Key facts

- **NCT ID:** NCT04326387
- **Lead sponsor:** CCTU- Cancer Theme
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-06
- **Primary completion:** 2021-04-07
- **Final completion:** 2021-10-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2020-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04326387

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04326387, "Evaluation of Novel Diagnostic Tests for COVID-19". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04326387. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*